Patient-derived organoids for prediction of treatment response in oesophageal adenocarcinoma

Br J Surg. 2024 Jan 3;111(1):znad408. doi: 10.1093/bjs/znad408.

Jarlath C Bolger^{1

2}, Jonathan Allen³, Nikolina Radulovich⁴, Christine Ng⁴, Mathieu Derouet³, Premalatha Shathasivam³, Gavin W Wilson³, Ming-Sound Tsao⁵, Elena Elimova⁶, Gail E Darling^{1

3}, Jonathan C Yeung^{1

3}

¹ Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
² Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.
³ Latner Thoracic Surgery Research Laboratories, Princess Margaret Cancer Research Tower, University Health Network, Toronto, Ontario, Canada.
⁴ Princess Margaret Living Biobank, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
⁵ Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
⁶ Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

No abstract available

MeSH terms